Blood and Saliva Sample Collection for AREDS 2
NCT01553474 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 56
Last updated 2019-07-29
Summary
Background:
\- The Age-Related Eye Disease Study 2 (AREDS 2) is looking at different eye diseases. Study participants will provide blood and saliva samples. The samples will be stored for research on eye diseases.
Objectives:
\- To collect blood and saliva samples for AREDS 2 research.
Eligibility:
\- AREDS 2 research study participants.
Design:
* Participants will provide blood and saliva samples.
* The samples will be submitted with personal and medical information. This information will be collected during the AREDS 2 procedures.
Conditions
- Age-Related Macular Degeneration
- Eye Diseases
Sponsors & Collaborators
-
National Eye Institute (NEI)
lead NIH
Principal Investigators
-
Wai T Wong, M.D. · National Eye Institute (NEI)
Eligibility
- Min Age
- 55 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-02-24
- Completion
- 2013-02-05
Countries
- United States
Study Locations
More Related Trials
-
Age-Related Eye Disease Study 2 (AREDS2)
NCT00345176 ·Status: COMPLETED ·Phase: PHASE3
-
Genetic Factors in Age-Related Macular Degeneration
NCT00058695 ·Status: TERMINATED
-
A Study to Evaluate Retisert in the Treatment of Patients With the "Wet" Form of Age-Related Macular Degeneration
NCT00032396 ·Status: UNKNOWN ·Phase: PHASE2
-
Safety Study in Retinal Transplantation for Dry Age Related Macular Degeneration.
NCT00346060 ·Status: COMPLETED ·Phase: PHASE2
-
Study of T-PRED(TM) Compared to Pred Forte(R) II
NCT00854061 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Sun Filters on Age-related Macular Degeneration in People With Lens Implants
NCT00487838 ·Status: WITHDRAWN
-
Dark Adaptation in Participants With Age-Related Macular Degeneration
NCT03225131 ·Status: ACTIVE_NOT_RECRUITING
-
Antioxidant Systems and Age-Related Macular Degeneration
NCT00668213 ·Status: COMPLETED
-
Evaluation of a New Eye-specific Multivitamin Formula in Participants at Risk of Age-related Macular Degeneration (AMD)
NCT03946085 ·Status: COMPLETED ·Phase: NA
-
Genetics and Markers of Degenerative and Inflammatory Eye Diseases
NCT00647439 ·Status: COMPLETED
-
Effect of Omega-3-fatty Acids on Blood Levels Omega-3 Fatty Acids in Patients With Age-related Macular Degeneration
NCT01653184 ·Status: COMPLETED ·Phase: NA
-
Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations
NCT07265895 ·Status: NOT_YET_RECRUITING
-
Possible Effects of Supplement Therapy With Oral Phenolics on Cluster of Differentiation 163 (CD-163) Biomarker of Patients With Age-related Macular Degeneration
NCT05005884 ·Status: UNKNOWN ·Phase: PHASE1
-
Can the Risk for AMD be Modulated?
NCT05735730 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Rod and Cone Mediated Function in Retinal Disease
NCT02617966 ·Status: RECRUITING
-
Gyrate Atrophy Ocular and Systemic Study
NCT05312736 ·Status: ACTIVE_NOT_RECRUITING
-
Lutein by Scleral Iontophoresis in AMD
NCT06925893 ·Status: RECRUITING
-
Age-related Macular Degeneration (AMD) and Cardiovascular Disease
NCT04087356 ·Status: UNKNOWN
-
The Role of the Gut Metagenome on the Development of Age Related Macular Degeneration (AMD)
NCT02438111 ·Status: UNKNOWN
-
Functionally Validated Structural Endpoints for Early AMD
NCT04112667 ·Status: COMPLETED
-
Vitamin A Palmitate Supplementation in People With Age-Related Macular Degeneration (and Without Reticular Pseudodrusen) and Delayed Dark Adaptation
NCT03478865 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Oxidative Stress in Patients With Age-Related Macular Degeneration
NCT00465400 ·Status: COMPLETED
-
Randomized Trials of Vitamin Supplements and Eye Disease
NCT00000161 ·Status: UNKNOWN ·Phase: PHASE3
-
Collaborative Italian-American Clinical Trial of Nutritional Supplements and Age-related Cataract (CTNS)
NCT00309387 ·Status: COMPLETED ·Phase: PHASE3
-
Lutein for Age-Related Macular Degeneration
NCT00006202 ·Status: COMPLETED ·Phase: PHASE2